Bulletin
Investor Alert

Market Pulse Archives

May 24, 2022, 7:52 a.m. EDT

Insulet's stock is up on Bloomberg report that it may be acquired by Dexcom

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Insulet Corp. (PODD)
  • X
    DexCom Inc. (DXCM)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Insulet Corp. /zigman2/quotes/205106258/composite PODD -0.59% gained 9.9% in premarket trading on Tuesday, the day after Bloomberg reported that the company is in talks to be acquired by Dexcom Inc. /zigman2/quotes/201324608/composite DXCM -0.14% , citing anonymous sources. Dexcom's stock was down 7.1% before the market opened on Tuesday. A tie-up between the companies would create a major player in the diabetes sector. Dexcom manufactures continuous glucose monitoring systems, while Insulet makes a disposable insulin delivery system. Insulet CEO Shacey Petrovic announced earlier this month that she's stepping down June 1 for family reasons. Insulet's stock is down 23.7% this year, while the broader S&P 500 /zigman2/quotes/210599714/realtime SPX +0.36% has slid 18.1%.

/zigman2/quotes/205106258/composite
US : U.S.: Nasdaq
$ 230.32
-1.36 -0.59%
Volume: 337,969
July 6, 2022 4:00p
P/E Ratio
370.05
Dividend Yield
N/A
Market Cap
$16.06 billion
Rev. per Employee
$496,478
loading...
/zigman2/quotes/201324608/composite
US : U.S.: Nasdaq
$ 78.35
-0.11 -0.14%
Volume: 2.81M
July 6, 2022 4:00p
P/E Ratio
151.34
Dividend Yield
N/A
Market Cap
$30.80 billion
Rev. per Employee
$408,302
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,845.08
+13.69 +0.36%
Volume: 2.20B
July 6, 2022 5:43p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.